BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24741005)

  • 1. Novel polymeric nanoparticles for intracellular delivery of peptide Cargos: antitumor efficacy of the BCL-2 conversion peptide NuBCP-9.
    Kumar M; Gupta D; Singh G; Sharma S; Bhat M; Prashant CK; Dinda AK; Kharbanda S; Kufe D; Singh H
    Cancer Res; 2014 Jun; 74(12):3271-81. PubMed ID: 24741005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular delivery of peptide cargos using polyhydroxybutyrate based biodegradable nanoparticles: Studies on antitumor efficacy of BCL-2 converting peptide, NuBCP-9.
    Kapoor S; Gupta D; Kumar M; Sharma S; Gupta AK; Misro MM; Singh H
    Int J Pharm; 2016 Sep; 511(2):876-89. PubMed ID: 27492021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular delivery of peptide cargos using iron oxide based nanoparticles: studies on antitumor efficacy of a BCL-2 converting peptide, NuBCP-9.
    Kumar M; Singh G; Sharma S; Gupta D; Bansal V; Arora V; Bhat M; Srivastava SK; Sapra S; Kharbanda S; Dinda AK; Singh H
    Nanoscale; 2014 Nov; 6(23):14473-83. PubMed ID: 25340469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular Targeting of the Oncogenic MUC1-C Protein with a Novel GO-203 Nanoparticle Formulation.
    Hasegawa M; Sinha RK; Kumar M; Alam M; Yin L; Raina D; Kharbanda A; Panchamoorthy G; Gupta D; Singh H; Kharbanda S; Kufe D
    Clin Cancer Res; 2015 May; 21(10):2338-47. PubMed ID: 25712682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant Delivery of Paclitaxel and NuBCP-9 peptide for synergistic enhancement of cancer therapy.
    Gupta D; Kumar M; Tyagi P; Kapoor S; Tyagi A; Barman TK; Kharbanda S; Kufe D; Singh H
    Nanomedicine; 2018 Jun; 14(4):1301-1313. PubMed ID: 29641982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.
    Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S
    Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymer-polymer conjugation to fabricate multi-block polymer as novel drug carriers: poly(lactic acid)-poly(ethylene glycol)-poly(L-lysine) to enhance paclitaxel target delivery.
    Liu Y; Liu C; Li M; Liu F; Feng L; Zhang L; Zhang N
    J Biomed Nanotechnol; 2014 Jun; 10(6):948-58. PubMed ID: 24749390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel pH-sensitive charge-reversal cell penetrating peptide conjugated PEG-PLA micelles for docetaxel delivery: in vitro study.
    Ouahab A; Cheraga N; Onoja V; Shen Y; Tu J
    Int J Pharm; 2014 May; 466(1-2):233-45. PubMed ID: 24614579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A short Nur77-derived peptide converts Bcl-2 from a protector to a killer.
    Kolluri SK; Zhu X; Zhou X; Lin B; Chen Y; Sun K; Tian X; Town J; Cao X; Lin F; Zhai D; Kitada S; Luciano F; O'Donnell E; Cao Y; He F; Lin J; Reed JC; Satterthwait AC; Zhang XK
    Cancer Cell; 2008 Oct; 14(4):285-98. PubMed ID: 18835031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained release of PTX-incorporated nanoparticles synergized by burst release of DOX⋅HCl from thermosensitive modified PEG/PCL hydrogel to improve anti-tumor efficiency.
    Xu S; Wang W; Li X; Liu J; Dong A; Deng L
    Eur J Pharm Sci; 2014 Oct; 62():267-73. PubMed ID: 24931190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymeric nano-encapsulation of 5-fluorouracil enhances anti-cancer activity and ameliorates side effects in solid Ehrlich Carcinoma-bearing mice.
    Haggag YA; Osman MA; El-Gizawy SA; Goda AE; Shamloula MM; Faheem AM; McCarron PA
    Biomed Pharmacother; 2018 Sep; 105():215-224. PubMed ID: 29857301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligo(Lactic Acid)
    Tam YT; Repp L; Ma ZX; Feltenberger JB; Kwon GS
    Pharm Res; 2019 Mar; 36(5):70. PubMed ID: 30888509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
    Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
    Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-Penetrating Peptide Modified PEG-PLA Micelles for Efficient PTX Delivery.
    Shuai Q; Cai Y; Zhao G; Sun X
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Particle characteristics and biodistribution of camptothecin-loaded PLA/(PEG-PPG-PEG) nanoparticles.
    Kunii R; Onishi H; Ueki K; Koyama K; Machida Y
    Drug Deliv; 2008 Jan; 15(1):3-10. PubMed ID: 18197517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galactose-decorated reduction-sensitive degradable chimaeric polymersomes as a multifunctional nanocarrier to efficiently chaperone apoptotic proteins into hepatoma cells.
    Wang X; Sun H; Meng F; Cheng R; Deng C; Zhong Z
    Biomacromolecules; 2013 Aug; 14(8):2873-82. PubMed ID: 23815094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Copper-Mediated Disulfiram-Loaded pH-Triggered PEG-Shedding TAT Peptide-Modified Lipid Nanocapsules for Use in Tumor Therapy.
    Zhang L; Tian B; Li Y; Lei T; Meng J; Yang L; Zhang Y; Chen F; Zhang H; Xu H; Zhang Y; Tang X
    ACS Appl Mater Interfaces; 2015 Nov; 7(45):25147-61. PubMed ID: 26501354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel.
    Ruan G; Feng SS
    Biomaterials; 2003 Dec; 24(27):5037-44. PubMed ID: 14559017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
    Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS
    Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.